Neurodon Overview

  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $500K
Latest Deal Amount
  • Investors
  • 1

Neurodon General Information

Description

Developer of a new healthcare technology intended to provide effective way to treat Parkinson's disease. The company novel strategy focuses halting the process of endoplasmic reticulum stress, which is a major cause of the disease, providing healthcare professionals with new technology and medicines that can effectively cure Parkinson's disease as well as Alzheimer's disease and Huntington's disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 9800 Conneticuit Drive
  • Crown Point, IN 46307
  • United States
+1 (219) 000-0000

Neurodon Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurodon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 17-Oct-2019 $500K 00000 Completed Startup
1. Grant 01-Jan-2018 00000 Completed Startup
To view Neurodon’s complete valuation and funding history, request access »

Neurodon Executive Team (1)

Name Title Board Seat Contact Info
Russell Dahl Ph.D Scientific Founder, Board Member & Chief Executive Officer
To view Neurodon’s complete executive team members history, request access »

Neurodon Board Members (1)

Name Representing Role Since
Russell Dahl Ph.D Neurodon Scientific Founder, Board Member & Chief Executive Officer 000 0000
To view Neurodon’s complete board members history, request access »

Neurodon Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Neurodon’s complete investors history, request access »